Dr. Sukhmani K. Padda, an assistant professor of medicine at Stanford University, discusses emerging therapeutic strategies for several rare mutations in NSCLC including ROS1. http://www.onclive.com/conference-coverage/mlcc-2018/novel-agents-emerging-for-lesserknown-targets-in-nsclc?p=1
For two weeks in August, 2015, I had whole brain radiation therapy. Ten days of being locked to a table for seven-minute sessions intended to slow or stop the growth of the metastatic cancer in my brain. During treatments I saw blue lights and smelled chlorine, neither of which were in the room, a testament … Continue reading My Hair is Coming Back!
Well, I did it again. During the first hour of the first day of registration for the 2016 Pan Mass Challenge, I went to their website and paid the $235 fee to register. I’m not sure why I was in such a hurry to do so. Happily there were some donors who seemed in a … Continue reading Riding the PMC